CTRI/2022/12/047991招募中未知
Evaluation of host-based biomarkers for diagnosis and determining the progress of treatment in tuberculosis patients.
HealthSeq Precision Medicine Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •(a) Age 18 and above
- •(b) Treatment-naive patients at zero week
- •(c) Sputum positive for AFB or GenXpert/ Truenat/ CBNAAT TB test positive, with the diagnosis confirmed by a clinician
- •(d) completing 24 weeks or recommended duration of ATT.
排除标准
- •a) Individuals on alternate treatment forms - e.g. Ayurveda, homeopathy, etc
- •(b) Individuals with comorbidities such as HIV, proven malignancy, COVID-19
- •(c) Pregnancy or lactation
- •(d) are on Immunosuppressants
研究者
相似试验
招募中
不适用
Investigation of biomarkers for diagnosis and treatment of pulmonary hypertension.Pulmonary hypertensionJPRN-UMIN000032888Juntendo University50
招募中
不适用
Validation of specific biomarkers for the diagnosis of endometriosisNL-OMON49755198865
招募中
不适用
Identification of biomarkers for diagnosis and prognosis in the patients with obstructive sleep apneaobstructive sleep apneaJPRN-UMIN000021503Osaka university graduate School of medicine The department of geriatric and general medicine200
已完成
不适用
Development and evaluation of diagnostic biomarker panels on the basis of microarray analysis for treatment planning of oral squamous cell carcinomaoral squamous cell carcinomaC06.9Mouth, unspecifiedDRKS00000199Pro Inno IIAiF Projekt GmbH80
已完成
Unknown
Predicting the outcomes from acute lower respiratory tract infections at the point of needSepsis in patients with lower respiratory tract infectionsInfections and InfestationsISRCTN96762081Portsmouth Hospitals NHS Trust600